ClinConnect ClinConnect Logo
Search / Trial NCT02995603

Patient Experience and Acceptance of Horizontal Rotation

Launched by UNIVERSITY OF SYDNEY · Dec 13, 2016

Trial Information

Current as of August 20, 2025

Recruiting

Keywords

Radiotherapy Rotation

ClinConnect Summary

This clinical trial is looking at how patients with cancer feel about a new system that rotates them horizontally at different speeds. The goal is to understand their experiences and acceptance of this rotation, which could help improve treatments in the future. Participants will fill out surveys designed to measure their feelings and experiences during the rotation process.

To be eligible for this trial, you need to be at least 18 years old and have a cancer diagnosis at any stage. You should also be currently or previously treated with radiotherapy. It’s important that you can read and complete questionnaires in English and are willing to follow the study's requirements. However, pregnant women and those with certain medical conditions that might affect their ability to give consent or experience severe dizziness are not eligible. If you choose to participate, you will play a vital role in helping researchers better understand how this rotation affects patients like you.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. A diagnosis of cancer, any stage
  • 2. ≥18 years of age
  • 3. Eastern Cooperative Oncology Group (ECOG) status 0-2
  • 4. Currently or previously being treated with radiotherapy
  • 5. Any prior therapy allowed
  • 6. Willing and able to comply with all study requirements
  • 7. Must be able to read and complete questionnaires in English
  • 8. Signed, written informed consent
  • Exclusion Criteria:
  • 1. Pregnant women
  • 2. Mentally impaired patients or patients for whom attaining informed consent would be difficult (including language barriers)
  • 3. Severe vertigo or recent diagnosis of Benign Paroxysmal Positioning Vertigo

About University Of Sydney

The University of Sydney is a leading research institution in Australia, renowned for its commitment to advancing medical science and improving healthcare outcomes through innovative clinical trials. With a robust infrastructure and a multidisciplinary team of experts, the university fosters a collaborative environment that integrates cutting-edge research with clinical practice. The institution emphasizes ethical standards, patient safety, and scientific rigor in its trials, aiming to translate findings into real-world applications that benefit diverse populations. Through its dedication to excellence and impact, the University of Sydney continues to contribute significantly to the fields of medicine and public health.

Locations

Randwick, New South Wales, Australia

Patients applied

0 patients applied

Trial Officials

Paul Keall, Prof

Study Chair

University of Sydney

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials